Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors

Medicine & Life Sciences

• ATP Binding Cassette Transporter, Subfamily G, Member 2 100%
• Human immunodeficiency virus 1 reverse transcriptase 89%
• Reverse Transcriptase Inhibitors 78%
• Nucleosides 68%
• HIV-1 56%
• Breast Neoplasms 41%
• Doxorubicin 21%
• ATP Binding Cassette Transporter, Subfamily B, Member 1 12%
• tryptoquivaline 10%
• major vault protein 9%
• Adenosine Triphosphate 9%
• P-glycoprotein 2 8%
• Rhodamine 123 8%
• Mitoxantrone 7%
• Lamivudine 7%
• Zidovudine 7%
• ATP-Binding Cassette Transporters 7%
• Irinotecan 6%
• Multiple Drug Resistance 6%
• Protease Inhibitors 6%
• Virus Replication 5%
• Antineoplastic Agents 5%
• Antiviral Agents 5%
• T-Lymphocytes 3%
• Cell Line 3%
• Neoplasms 1%